Elixinol Wellness Ltd (EXL) - Net Assets

Latest as of December 2025: AU$7.45 Million AUD ≈ $5.27 Million USD

Based on the latest financial reports, Elixinol Wellness Ltd (EXL) has net assets worth AU$7.45 Million AUD (≈ $5.27 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$15.96 Million ≈ $11.30 Million USD) and total liabilities (AU$8.51 Million ≈ $6.02 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check EXL tangible net assets ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	AU$7.45 Million
% of Total Assets	46.68%
Annual Growth Rate	-11.29%
5-Year Change	-60.94%
10-Year Change	-92.5%
Growth Volatility	47.38

Elixinol Wellness Ltd - Net Assets Trend (2002–2025)

This chart illustrates how Elixinol Wellness Ltd's net assets have evolved over time, based on quarterly financial data. See operational self-sufficiency of Elixinol Wellness Ltd to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Elixinol Wellness Ltd (2002–2025)

The table below shows the annual net assets of Elixinol Wellness Ltd from 2002 to 2025. For live valuation and market cap data, see EXL company net worth.

Year	Net Assets	Change
2025-12-31	AU$7.45 Million ≈ $5.27 Million	-25.67%
2024-12-31	AU$10.03 Million ≈ $7.09 Million	+55.15%
2023-12-31	AU$6.46 Million ≈ $4.57 Million	-29.44%
2022-12-31	AU$9.16 Million ≈ $6.48 Million	-51.99%
2021-12-31	AU$19.08 Million ≈ $13.50 Million	-46.49%
2020-12-31	AU$35.65 Million ≈ $25.23 Million	-67.99%
2019-12-31	AU$111.38 Million ≈ $78.81 Million	-22.51%
2018-12-31	AU$143.74 Million ≈ $101.70 Million	+45.06%
2017-12-31	AU$99.09 Million ≈ $70.11 Million	-0.33%
2016-12-31	AU$99.42 Million ≈ $70.34 Million	-74.69%
2005-12-31	AU$392.73 Million ≈ $277.88 Million	+50.56%
2004-12-31	AU$260.84 Million ≈ $184.56 Million	+48.89%
2003-12-31	AU$175.18 Million ≈ $123.95 Million	+49.41%
2002-12-31	AU$117.25 Million ≈ $82.96 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Elixinol Wellness Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 975.6% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Common Stock	AU$229.88 Million	3084.82%
Other Comprehensive Income	AU$10.87 Million	145.81%
Total Equity	AU$7.45 Million	100.00%

Elixinol Wellness Ltd Competitors by Market Cap

The table below lists competitors of Elixinol Wellness Ltd ranked by their market capitalization.

Company	Market Cap
Aker Carbon Capture ASA OL:ACC	$2.05 Million
Brickability Group Plc LSE:BRCK	$2.06 Million
ELEMENT NUTR.SCIENCES F:93X	$2.06 Million
InMed Pharmaceuticals Inc NASDAQ:INM	$2.06 Million
Planet Properindo Jaya Pt JK:PLAN	$2.05 Million
Ferrexpo PLC LSE:FXPO	$2.05 Million
Sri Havisha Hospitality and Infrastructure Limited NSE:HAVISHA	$2.04 Million
INLIF LIMITED Ordinary Shares NASDAQ:INLF	$2.04 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Elixinol Wellness Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 10,026,000 to 7,452,000, a change of -2,574,000 (-25.7%).
Net loss of 5,500,000 reduced equity.
Share repurchases of 339,000 reduced equity.
New share issuances of 2,688,000 increased equity.
Other comprehensive income increased equity by 1,256,000.
Other factors decreased equity by 679,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	AU$-5.50 Million	-73.81%
Share Repurchases	AU$339.00K	-4.55%
Share Issuances	AU$2.69 Million	+36.07%
Other Comprehensive Income	AU$1.26 Million	+16.85%
Other Changes	AU$-679.00K	-9.11%
Total Change	AU$-	-25.67%

Book Value vs Market Value Analysis

This analysis compares Elixinol Wellness Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.24x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has increased from 0.00x to 0.24x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	AU$3.43	AU$0.01	x
2017-12-31	AU$0.65	AU$0.01	x
2018-12-31	AU$1.09	AU$0.01	x
2019-12-31	AU$0.57	AU$0.01	x
2020-12-31	AU$0.15	AU$0.01	x
2021-12-31	AU$0.05	AU$0.01	x
2022-12-31	AU$0.02	AU$0.01	x
2023-12-31	AU$0.01	AU$0.01	x
2024-12-31	AU$0.06	AU$0.01	x
2025-12-31	AU$0.03	AU$0.01	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Elixinol Wellness Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -73.81%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -35.48%
• Asset Turnover: 0.97x
• Equity Multiplier: 2.14x
Recent ROE (-73.81%) is below the historical average (-52.42%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2002	28.25%	18.22%	0.60x	2.59x	AU$16.47 Million
2003	17.26%	13.88%	0.57x	2.17x	AU$10.80 Million
2004	26.91%	17.57%	0.59x	2.61x	AU$39.50 Million
2005	26.75%	18.93%	0.54x	2.63x	AU$61.41 Million
2017	-2.74%	-135550.00%	0.00x	1.06x	AU$-12.62 Million
2018	-0.60%	-2.32%	0.24x	1.07x	AU$-15.23 Million
2019	-72.36%	-262.50%	0.25x	1.09x	AU$-91.77 Million
2020	-293.14%	-696.24%	0.35x	1.19x	AU$-108.07 Million
2021	-89.24%	-182.32%	0.37x	1.33x	AU$-18.93 Million
2022	-115.43%	-149.84%	0.52x	1.47x	AU$-11.49 Million
2023	-116.17%	-90.78%	0.71x	1.81x	AU$-8.15 Million
2024	-17.18%	-11.51%	0.81x	1.84x	AU$-2.72 Million
2025	-73.81%	-35.48%	0.97x	2.14x	AU$-6.25 Million

Industry Comparison

This section compares Elixinol Wellness Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $20,444,591
Average return on equity (ROE) among peers: -71.85%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Elixinol Wellness Ltd (EXL)	AU$7.45 Million	28.25%	1.14x	$2.05 Million
Althea Group Holdings Ltd (AGH)	$-574.00K	0.00%	0.00x	$12.05 Million
BOD Science Ltd (BOD)	$-703.36K	0.00%	0.00x	$3.01 Million
BPH Global Ltd (BP8)	$5.19 Million	5.27%	1.52x	$3.33 Million
Cann Group Ltd (CAN)	$13.92 Million	-368.09%	5.66x	$4.60 Million
ECS Botanics Holdings Ltd (ECS)	$11.85 Million	-167.95%	1.85x	$4.52 Million
Ecofibre Ltd (EOF)	$74.65 Million	-53.47%	0.59x	$5.36 Million
Epsilon Healthcare Ltd (EPN)	$25.32 Million	-43.24%	0.47x	$6.06 Million
IDT Australia Ltd (IDT)	$48.92 Million	-1.58%	0.19x	$10.28 Million
Invion Ltd (IVX)	$5.43 Million	-17.55%	0.06x	$2.61 Million

About Elixinol Wellness Ltd

AU:EXL Australia Drug Manufacturers - Specialty & Generic

Market Cap

$2.05 Million

AU$2.90 Million AUD

Market Cap Rank

#29939 Global

#1758 in Australia

Share Price

AU$0.01

Change (1 day)

+16.67%

52-Week Range

AU$0.01 - AU$0.02

All Time High

AU$4.91